Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918287 | Radiotherapy and Oncology | 2015 | 4 Pages |
Abstract
This study assessed the prophylactic bethanechol use to prevent salivary gland dysfunction during radiotherapy. A total of 97 head and neck cancer patients were allocated into two groups: Bethanechol or Placebo. Bethanechol group presented significantly improve of salivary parameters. Bethanechol was effective in decreasing the salivary gland damage.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Graziella Chagas Jaguar, Eduardo Nóbrega Pereira Lima, Luiz Paulo Kowalski, Antônio Cássio Pellizzon, André Lopes Carvalho, Karina Waiswol Boccaletti, Fabio Abreu Alves,